85 related articles for article (PubMed ID: 8639546)
1. Flavins inhibit human cytomegalovirus UL80 protease via disulfide bond formation.
Baum EZ; Ding WD; Siegel MM; Hulmes J; Bebernitz GA; Sridharan L; Tabei K; Krishnamurthy G; Carofiglio T; Groves JT; Bloom JD; DiGrandi M; Bradley M; Ellestad G; Seddon AP; Gluzman Y
Biochemistry; 1996 May; 35(18):5847-55. PubMed ID: 8639546
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human cytomegalovirus UL80 protease by specific intramolecular disulfide bond formation.
Baum EZ; Siegel MM; Bebernitz GA; Hulmes JD; Sridharan L; Sun L; Tabei K; Johnston SH; Wildey MJ; Nygaard J; Jones TR; Gluzman Y
Biochemistry; 1996 May; 35(18):5838-46. PubMed ID: 8639545
[TBL] [Abstract][Full Text] [Related]
3. Investigating the origin of the slow-binding inhibition of HCV NS3 serine protease by a novel substrate based inhibitor.
Liu Y; Saldivar A; Bess J; Solomon L; Chen CM; Tripathi R; Barrett L; Richardson PL; Molla A; Kohlbrenner W; Kati W
Biochemistry; 2003 Jul; 42(29):8862-9. PubMed ID: 12873147
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the covalent modification of the catalytic triad of human cytomegalovirus protease by pseudo-reversible beta-lactam inhibitors and a peptide chloromethylketone.
Haley TM; Angier SJ; Borthwick AD; Montgomery DS; Purvis IJ; Smart DH; Bessant C; Van Wely C; Hart GJ
J Mass Spectrom; 1998 Dec; 33(12):1246-55. PubMed ID: 9875526
[TBL] [Abstract][Full Text] [Related]
5. The herpesvirus protease: mechanistic studies and discovery of inhibitors of the human cytomegalovirus protease.
Flynn DL; Becker DP; Dilworth VM; Highkin MK; Hippenmeyer PJ; Houseman KA; Levine LM; Li M; Moormann AE; Rankin A; Toth MV; Villamil CI; Wittwer AJ; Holwerda BC
Drug Des Discov; 1997 May; 15(1):3-15. PubMed ID: 9332827
[TBL] [Abstract][Full Text] [Related]
6. Human pancreas-specific protein disulfide isomerase homolog (PDIp) is redox-regulated through formation of an inter-subunit disulfide bond.
Fu X; Zhu BT
Arch Biochem Biophys; 2009 May; 485(1):1-9. PubMed ID: 19150607
[TBL] [Abstract][Full Text] [Related]
7. Pyrimido[1,2-b]-1,2,4,5-tetrazin-6-ones as HCMV protease inhibitors: a new class of heterocycles with flavin-like redox properties.
Di Grandi MJ; Curran KJ; Baum EZ; Bebernitz G; Ellestad GA; Ding WD; Lang SA; Rossi M; Bloom JD
Bioorg Med Chem Lett; 2003 Oct; 13(20):3483-6. PubMed ID: 14505653
[TBL] [Abstract][Full Text] [Related]
8. Redox regulation of yeast flavin-containing monooxygenase.
Suh JK; Poulsen LL; Ziegler DM; Robertus JD
Arch Biochem Biophys; 2000 Sep; 381(2):317-22. PubMed ID: 11032421
[TBL] [Abstract][Full Text] [Related]
9. Evidence of a conformational change in the human cytomegalovirus protease upon binding of peptidyl-activated carbonyl inhibitors.
Bonneau PR; Grand-Maître C; Greenwood DJ; Lagacé L; LaPlante SR; Massariol MJ; Ogilvie WW; O'Meara JA; Kawai SH
Biochemistry; 1997 Oct; 36(41):12644-52. PubMed ID: 9376371
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides.
Kati WM; Sham HL; McCall JO; Montgomery DA; Wang GT; Rosenbrook W; Miesbauer L; Buko A; Norbeck DW
Arch Biochem Biophys; 1999 Feb; 362(2):363-75. PubMed ID: 9989947
[TBL] [Abstract][Full Text] [Related]
11. Thiol modification and site directed mutagenesis of the flavin domain of spinach NADH:nitrate reductase.
Trimboli AJ; Quinn GB; Smith ET; Barber MJ
Arch Biochem Biophys; 1996 Jul; 331(1):117-26. PubMed ID: 8660690
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the early stage of the folding process of reduced lysozyme using all lysozyme variants containing a pair of cysteines.
Shioi S; Imoto T; Ueda T
Biochemistry; 2004 May; 43(18):5488-93. PubMed ID: 15122914
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic activity of human cytomegalovirus UL80 protease cleavage site mutants.
Jones TR; Sun L; Bebernitz GA; Muzithras VP; Kim HJ; Johnston SH; Baum EZ
J Virol; 1994 Jun; 68(6):3742-52. PubMed ID: 8189512
[TBL] [Abstract][Full Text] [Related]
14. Pathway of oxidative folding of secretory leucocyte protease inhibitor: an 8-disulfide protein exhibits a unique mechanism of folding.
Lin CC; Chang JY
Biochemistry; 2006 May; 45(19):6231-40. PubMed ID: 16681396
[TBL] [Abstract][Full Text] [Related]
15. Residues critical for H-L disulfide bond formation in human IgA1 and IgA2.
Chintalacharuvu KR; Morrison SL
J Immunol; 1996 Oct; 157(8):3443-9. PubMed ID: 8871643
[TBL] [Abstract][Full Text] [Related]
16. Unique fold and active site in cytomegalovirus protease.
Qiu X; Culp JS; DiLella AG; Hellmig B; Hoog SS; Janson CA; Smith WW; Abdel-Meguid SS
Nature; 1996 Sep; 383(6597):275-9. PubMed ID: 8805707
[TBL] [Abstract][Full Text] [Related]
17. Increasing the reactivity of an artificial dithiol-disulfide pair through modification of the electrostatic milieu.
Hansen RE; Østergaard H; Winther JR
Biochemistry; 2005 Apr; 44(15):5899-906. PubMed ID: 15823049
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin reductase from Plasmodium falciparum: evidence for interaction between the C-terminal cysteine residues and the active site disulfide-dithiol.
Wang PF; Arscott LD; Gilberger TW; Müller S; Williams CH
Biochemistry; 1999 Mar; 38(10):3187-96. PubMed ID: 10074374
[TBL] [Abstract][Full Text] [Related]
19. The roles of surface loop insertions and disulfide bond in the stabilization of thermophilic WF146 protease.
Bian Y; Liang X; Fang N; Tang XF; Tang B; Shen P; Peng Z
FEBS Lett; 2006 Oct; 580(25):6007-14. PubMed ID: 17052711
[TBL] [Abstract][Full Text] [Related]
20. Design of fluorogenic peptide substrates for human cytomegalovirus protease based on structure-activity relationship studies.
Bonneau PR; Plouffe C; Pelletier A; Wernic D; Poupart MA
Anal Biochem; 1998 Jan; 255(1):59-65. PubMed ID: 9448842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
